Back
Share
Spinaker Alfa
VC firmSPINAKER Alfa, established in 2017 and headquartered in Łódź, Poland, is a seed capital fund focused on early-stage projects. The firm assists startups in validating their business ideas and products, connecting them with industry partners during the commercialization phase.
SPINAKER Alfa invests in sectors such as fintech, cleantech, health tech, energy, cloud software-as-a-service, Internet of Things, artificial intelligence, robotics, big data, medtech, information and communications technology, and blockchain. The firm has made 21 investments and has a portfolio of 14 companies, with 6 exits to date.
Specification
Stages
2. Prototype
3. Early Revenue
Target countries
Poland
Lead
Always
Tickets
$100k to $200k
Location
Wólczańska 125, 90-521 Łódź, Poland, Poland
Explore similar Venture Funds to Spinaker Alfa
We invest in early-stage post-revenue businesses operating in the creative industries, from content, to distribution, technology and any related se...
Specification
Target countries
UK
Stages
3. Early Revenue
4. Scaling
We invest in pre-seed and seed stage startups based in North America, LATAM, and Europe with strong founding teams and large market opportunities. ...
Specification
Target countries
USA
Canada
Mexico
Brazil
Argentina
Colombia
France
Switzerland
UK
Spain
Portugal
Germany
Italy
Norway
Sweden
Finland
Denmark
Poland
Ukraine
Romania
Greece
Serbia
Hungary
Slovakia
Slovenia
Croatia
Czech Republic
Australia
Chile
Uruguay
Stages
1. Idea or Patent
2. Prototype
+ 1
Trailhead Capital is a mission-driven investment firm based in Denver, Colorado, dedicated to creating outstanding financial, societal, and ecologi...
Specification
Target countries
Brazil
Australia
USA
Canada
Israel
Stages
3. Early Revenue
4. Scaling
We invest in visionary teams building companies of consequence, primarily investing in Series B through IPO stage technology companies.
Specification
Target countries
USA
Canada
UK
Germany
Austria
France
Netherlands
Stages
5. Growth
6. Pre-IPO
Okta Ventures is the corporate venture capital arm of Okta, a leading independent identity provider for enterprises. Established in 2019 with a $50...
Specification
Target countries
USA
Israel
UK
Stages
1. Idea or Patent
2. Prototype
+ 4
We invest globally in pioneering companies in genomics and precision health, in markets such as life science tools, clinical diagnostics, therapeut...
Specification
Target countries
USA
UK
France
Ireland
Stages
3. Early Revenue
2. Prototype